Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-up from a Community-based Cohort.

The long-term association between multiple cytokines and progression to diabetes is still uncertain.To identify what cytokines could predict progression to prediabetes and type 2 diabetes over the 10 years.The study included 912 participants aged 40 to 69 years at baseline from the Ansung cohort, part of the Korea Genome Epidemiology Study. At baseline, a 75-g oral glucose tolerance test and eight cytokines were measured: plasminogen-activator inhibitor-1 (PAI-1), resistin, interleukin-6, leptin, monocyte-chemoattractant-protein-1, tumor-necrosis-factor-alpha, retinol-binding-protein 4 (RBP4), and adiponectin. People with normal glucose tolerance (NGT, n = 241) and prediabetes (n = 330) were followed-up biennially for 10 years. Multinomial logistic regression analysis was used to evaluate the predictability of cytokines on the new-onset prediabetes and type 2 diabetes.At 10 years, 38 (15.8%) and 82 (34.0%) of those with NGT had converted to prediabetes and type 2 diabetes, respectively. Of those with prediabetes, 228 (69.1%) had converted to type 2 diabetes. In people with NGT or prediabetes at baseline, the highest tertile of RBP4 was associated with a 5.48-fold and 2.43-fold higher risk of progression to type 2 diabetes, respectively. The odds for converting from NGT to prediabetes in the highest tertile of PAI-1 and the lowest tertile of adiponectin were 3.23 and 3.37, respectively. In people with prediabetes at baseline, those in the highest tertile of resistin were 2.94 time more likely to develop type 2 diabetes (all p<0.05).In this 10-year prospective study, NGT with higher serum RBP4 and PAI-1, and with lower adiponectin were associated with new-onset prediabetes and type 2 diabetes.

Click here to read the full article @ The Journal of clinical endocrinology and metabolism